Stevanato Group (STVN) said Tuesday it has expanded its drug delivery system manufacturing capacity by adding a state-of-the-art production space for drug delivery devices at its facility in Bad Oeynhausen, northern Germany.

The company said the upgrade adds more than 2,500 square meters of advanced production space, including a new ISO 8 cleanroom for injection molding and automated assembly operations.

The multi-million-euro investment will enhance its capacity to serve pharma and biotech clients across Europe and beyond, the company added, adding that the facility will also support production of key devices such as the Aidaptus autoinjector and Alina pen injector.